Lucid Diagnostics Inc.: 10-Q filed 2026-05-13
What Lucid Diagnostics Inc. reported in its quarterly report filed 2026-05-13 (fiscal Q1 2026): 39 published measures, 80 facts as tagged in accession 0001437749-26-016751.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2026-05-13
- Fiscal period
- fiscal Q1 2026
- Accession
- 0001437749-26-016751 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lucid Diagnostics Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 34,080,000 | USD | |
| At 2025-12-31 | 40,445,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 30,080,000 | USD | |
| At 2025-12-31 | 29,509,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 4,000,000 | USD | |
| At 2025-12-31 | 10,936,000 | USD | |
| At 2025-03-31 | -5,377,000 | USD | |
| At 2024-12-31 | 5,391,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -13,909,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -26,908,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -12,101,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -12,465,000 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 215,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 93,000 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 5,487,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 15,438,000 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -215,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -93,000 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | -297,963,000 | USD | |
| At 2025-12-31 | -274,335,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 140,096,782 | shares | 90 |
| 2025-01-01 to 2025-03-31 | 68,796,392 | shares | 90 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -0.17 | USD/shares | 90 |
| 2025-01-01 to 2025-03-31 | -0.52 | USD/shares | 90 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 0 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 0 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 907,000 | USD | |
| At 2025-12-31 | 809,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -12,114,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -12,487,000 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 31,362,000 | USD | |
| At 2025-12-31 | 37,468,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 29,385,000 | USD | |
| At 2025-12-31 | 28,582,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 1,077,000 | USD | |
| At 2025-12-31 | 970,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 689,000 | USD | |
| At 2025-12-31 | 643,000 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 469,000 | USD | |
| At 2025-12-31 | 353,000 | USD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 1,625,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 1,551,000 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 1,206,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 1,428,000 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 164,878,638 | shares | |
| At 2025-12-31 | 131,098,762 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 291,664,000 | USD | |
| At 2025-12-31 | 230,866,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 1,591,000 | USD | |
| At 2025-12-31 | 1,806,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 1,603,000 | USD | |
| At 2025-12-31 | 1,820,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 210,000 | USD | |
| At 2025-12-31 | 315,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 10,000 | USD | |
| At 2025-12-31 | 47,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 2,200,000 | USD | |
| At 2025-12-31 | 2,719,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-03-31 | 2,328,000 | USD | |
| At 2025-12-31 | 1,767,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -13,909,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -26,908,000 | USD | 90 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -23,628,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -36,018,000 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 5,432,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 6,162,000 | USD | 90 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 222,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 221,000 | USD | 90 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 105,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 105,000 | USD | 90 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 6,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 9,000 | USD | 90 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | -1,795,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -14,421,000 | USD | 90 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 249,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 267,000 | USD | 90 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 46,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | 16,000 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-03-31 | 108,000 | USD | 90 |
| 2025-01-01 to 2025-03-31 | -412,000 | USD | 90 |
Inspect the source
- Entity
- Lucid Diagnostics Inc. / CIK 0001799011
- Captured
- 2026-09-21T17:32:25.713Z
- SEC response SHA-256
affd343510d62edd69fc49ce28bdc9da5b7ae8b6099e46b58ad0cf5326ad10d8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001799011.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))